170 related articles for article (PubMed ID: 21119540)
1. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.
Colombo C; Vajro P; Degiorgio D; Coviello DA; Costantino L; Tornillo L; Motta V; Consonni D; Maggiore G;
J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):73-83. PubMed ID: 21119540
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
[TBL] [Abstract][Full Text] [Related]
3. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
[TBL] [Abstract][Full Text] [Related]
4. Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
Tan YW; Ji HL; Lu ZH; Ge GH; Sun L; Zhou XB; Sheng JH; Gong YH
World J Gastroenterol; 2018 Nov; 24(41):4716-4720. PubMed ID: 30416319
[TBL] [Abstract][Full Text] [Related]
5. A new splicing site mutation of the ABCB4 gene in intrahepatic cholestasis of pregnancy with raised serum gamma-GT.
Tavian D; Degiorgio D; Roncaglia N; Vergani P; Cameroni I; Colombo R; Coviello DA
Dig Liver Dis; 2009 Sep; 41(9):671-5. PubMed ID: 19261551
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of exons 6, 8 and 9 of ABCB4 gene in children with Progressive Familial Intrahepatic Cholestasis type 3.
Fathy M; Kamal M; Al-Sharkawy M; Al-Karaksy H; Hassan N
Biomarkers; 2016 Nov; 21(7):573-7. PubMed ID: 27075526
[TBL] [Abstract][Full Text] [Related]
9. [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)].
Masmoudi A; Hadj-Taieb I; Kammon T; Mseddi M; Boudaya S; Chaabouni M; Hachicha M; Turki H
Ann Dermatol Venereol; 2008 Mar; 135(3):228-30. PubMed ID: 18374858
[No Abstract] [Full Text] [Related]
10. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
[TBL] [Abstract][Full Text] [Related]
11. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
[TBL] [Abstract][Full Text] [Related]
12. Elevation of gamma-glutamyl transferase in adult: Should we think about progressive familiar intrahepatic cholestasis?
Oliveira HM; Pereira C; Santos Silva E; Pinto-Basto J; Pessegueiro Miranda H
Dig Liver Dis; 2016 Feb; 48(2):203-5. PubMed ID: 26699824
[TBL] [Abstract][Full Text] [Related]
13. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).
Degiorgio D; Colombo C; Seia M; Porcaro L; Costantino L; Zazzeron L; Bordo D; Coviello DA
Eur J Hum Genet; 2007 Dec; 15(12):1230-8. PubMed ID: 17726488
[TBL] [Abstract][Full Text] [Related]
15. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
Ziol M; Barbu V; Rosmorduc O; Frassati-Biaggi A; Barget N; Hermelin B; Scheffer GL; Bennouna S; Trinchet JC; Beaugrand M; Ganne-Carrié N
Gastroenterology; 2008 Jul; 135(1):131-41. PubMed ID: 18482588
[TBL] [Abstract][Full Text] [Related]
16. [Progressive familial intrahepatic cholestasis presenting as liver failure].
Sangorrin Iranzo A; Iriondo Sanz M; Alvarez García L; Jara Vega P; Martín de Carpi J
An Pediatr (Barc); 2009 Dec; 71(6):510-3. PubMed ID: 19811957
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
[TBL] [Abstract][Full Text] [Related]
18. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
Chen HL; Chang PS; Hsu HC; Lee JH; Ni YH; Hsu HY; Jeng YM; Chang MH
Pediatr Res; 2001 Jul; 50(1):50-5. PubMed ID: 11420418
[TBL] [Abstract][Full Text] [Related]
19. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
[TBL] [Abstract][Full Text] [Related]
20. [Benign recurrent cholestasis. Apropos of a case with normal serum gamma-glutamyl transpeptidase level].
Lachaux A; Loras-Duclaux I; Bouvier R; Fournier V; Regragui K; Hermier M
Pediatrie; 1993; 48(2):163-5. PubMed ID: 8101650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
